Finance

Lists
4015:TADAWUL
Jamjoom Pharmaceuticals Fctry Cmpny SJSC
SAR 123,40
+0,08%
(+0,100) 1D
13 Okt., 15:19:08 GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4015...
Open
SAR 123,30
High
SAR 125,50
Low
SAR 123,30
Mkt. cap
8,64 mjd
Avg. vol.
34,82 k
Volume
38,88 k
Dividend
3,40%
Quarterly dividend
SAR 1,05
Ex-dividend date
02 Aug. 2026
P/E ratio
17,97
52-wk high
SAR 165,30
52-wk low
SAR 123,30
EPS
SAR 6,87
Shares outstanding
29,31 m
No. of employees
1 k
Open
SAR 123,30
High
SAR 125,50
Low
SAR 123,30
Mkt. cap
8,64 mjd
Avg. vol.
34,82 k
Volume
38,88 k
Dividend
3,40%
Quarterly dividend
SAR 1,05
Ex-dividend date
02 Aug. 2026
P/E ratio
17,97
52-wk high
SAR 165,30
52-wk low
SAR 123,30
EPS
SAR 6,87
Shares outstanding
29,31 m
No. of employees
1 k
News stories
From web sources and news partners
About Jamjoom Pharmaceuticals Fctry Cmpny SJSC
CEO-
Employees1,13 k
Founded1994
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
342,31 m
304,57 m
481,38 m
445,31 m
Cost of goods sold
133,77 m
121,19 m
171,00 m
151,66 m
Cost of revenue
133,77 m
121,19 m
171,00 m
151,66 m
Research and development expenses
9,47 m
10,86 m
9,40 m
10,94 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
90,86 m
110,53 m
125,39 m
139,66 m
Operating expense
98,61 m
111,72 m
138,01 m
147,65 m
Total operating expenses
232,38 m
232,91 m
309,01 m
299,32 m
Operating income
109,92 m
71,66 m
172,38 m
146,00 m
Other non operating income
-
-1,17 m
-
-
EBT including unusual items
113,34 m
76,91 m
174,94 m
146,22 m
EBT excluding unusual items
113,34 m
77,01 m
174,94 m
146,22 m
Income tax expense
6,67 m
8,84 m
6,73 m
8,59 m
Effective tax rate
5,89%
11,49%
3,85%
5,87%
Other operating expenses
-1,72 m
-8,56 m
3,22 m
-2,95 m
Net income
106,67 m
68,07 m
168,21 m
137,63 m
Net profit margin
31,16%
22,35%
34,94%
30,91%
Earnings per share
-
-
-
-
Interest and investment income
991,15 k
784,73 k
2,32 m
1,36 m
Interest expense
-353,59 k
-
-1,54 m
-954,23 k
Net interest expenses
637,55 k
784,73 k
785,30 k
408,85 k
Depreciation and amortization charges
-
-
-
-
EBITDA
120,95 m
82,25 m
183,73 m
157,44 m
Gain or loss from assets sale
18,06 k
8,39 k
34,74 k
1,30 k
AI content may include mistakes. Learn more
Google-programme